Profile
| Metric | Value |
|---|---|
| Full Name | Arcturus Therapeutics Holdings Inc. |
| Ticker | NASDAQ: ARCT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | arcturusrx.com |
| Employees | 174 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $7.53 | |
| Price, 1D Change | +11.06% | |
| $214M | ||
| - | ||
| - | ||
| 1.59 | ||
| $138M | ||
| Revenue, 1Y Change | -12.27% | |
| -$3.00 | ||
| EPS, 1Y Change | -168.55% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:7 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ADHD | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.00 | ||
| EPS Estimate | -$2.08 | |
| EPS Est. Change | +30.71% | |
| $138.39M | ||
| Revenue Estimate | $90.41M | |
| Revenue Est. Change | -34.67% | |
| Current Price | $7.53 | |
| Price Target | - | $21.50 |
| Price Tgt. Change | - | +185.52% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.78 | -$1.12 | +37.29% | |
| -$2.38 | -$3.00 | -25.95% | |
| -$2.08 | N/A | +30.71% | |
| -$2.51 | N/A | +16.44% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $173.80M | $157.75M | -9.24% | |
| $174.23M | $138.39M | -20.57% | |
| $90.41M | N/A | -34.67% | |
| $67.88M | N/A | -50.95% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $7.53 | |
| $12.67 | ||
| SMA 200 vs Price | +68.24% | |
| $7.16 | ||
| SMA 50 vs Price | -4.87% | |
| 1.59 | ||
| $0.41 | ||
| 58.64 | ||
| 56.74% | ||
| 97.48% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $138.39M | ||
| -$3.00 | ||
| $134.85M | ||
| 97.44% | ||
| -$95.67M | ||
| -28.27% | ||
| -$80.94M | ||
| -58.49% | ||
| -$77.40M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.12 | ||
| 4.67 | ||
| 4.67 | ||
| - | ||
| 3 | ||
| -0.12 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 2.51 | ||
| 0.95 | ||
| -0.08 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $240.98M | ||
| $237.03M | ||
| $344.07M | ||
| $305.98M | ||
| $103.09M | ||
| $65.49M | ||
| $28.55M | ||
| $3.55M | ||
| $7.19M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $234.06M | ||
| $234.06M | ||
| $3.54M | ||
| $52.82M | ||
| $3.54M | ||
| $0.00 | ||
| -$4,000.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$59.75M | ||
| -$648.00K | ||
| $5.42M | ||
| $648.00K | ||
| -$60.40M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citigroup | → | |
| Citigroup | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Wells Fargo | → | |
| Guggenheim | → | |
| Citigroup | → | |
| Guggenheim | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with ARCT
Data Sources & References
- ARCT Official Website arcturusrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1768224/000119312525275758/0001193125-25-275758-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1768224/000095017025034787/0000950170-25-034787-index.htm
- ARCT Profile on Yahoo Finance finance.yahoo.com/quote/ARCT
- ARCT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arct
FAQ
What is the ticker symbol for Arcturus Therapeutics Holdings Inc.?
The ticker symbol for Arcturus Therapeutics Holdings Inc. is NASDAQ:ARCT
Does Arcturus Therapeutics Holdings Inc. pay dividends?
No, Arcturus Therapeutics Holdings Inc. does not pay dividends
What sector is Arcturus Therapeutics Holdings Inc. in?
Arcturus Therapeutics Holdings Inc. is in the Healthcare sector
What industry is Arcturus Therapeutics Holdings Inc. in?
Arcturus Therapeutics Holdings Inc. is in the Biotechnology industry
What country is Arcturus Therapeutics Holdings Inc. based in?
Arcturus Therapeutics Holdings Inc. is headquartered in United States
When did Arcturus Therapeutics Holdings Inc. go public?
Arcturus Therapeutics Holdings Inc. initial public offering (IPO) was on May 22, 2013
Is Arcturus Therapeutics Holdings Inc. in the S&P 500?
No, Arcturus Therapeutics Holdings Inc. is not included in the S&P 500 index
Is Arcturus Therapeutics Holdings Inc. in the NASDAQ 100?
No, Arcturus Therapeutics Holdings Inc. is not included in the NASDAQ 100 index
Is Arcturus Therapeutics Holdings Inc. in the Dow Jones?
No, Arcturus Therapeutics Holdings Inc. is not included in the Dow Jones index
When was Arcturus Therapeutics Holdings Inc. last earnings report?
Arcturus Therapeutics Holdings Inc.'s most recent earnings report was on November 10, 2025
When does Arcturus Therapeutics Holdings Inc. report earnings?
The next expected earnings date for Arcturus Therapeutics Holdings Inc. is March 5, 2026